This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Barrows, G. H. Articles by Christopherson, W. M. Search for Related Content PubMed Articles by Barrows, G. H. Articles by Christopherson, W. M. Social Bookmarking                         What's this?

Human Liver Neoplasia and Steroid Exposure

Assistant Professor of Pathology, University of Louisville School of Medicine, Louisville, Kentucky 40292 and James Graham Brown Cancer Center, Louisville, Kentucky 40202

E. Truman Mays, M.D.

Clinical Professor of Surgery, University of Kentucky College of Medicine, Lexington, Kentucky 40506

William M. Christopherson, M.D.

Professor of Pathology, University of Louisville School of Medicine, Louisville, Kentucky 40292 and James Graham Brown Cancer Center, Louisville, Kentucky 40202

This study examines experience with over 250 liver tumors in young women. Most were oral contraceptive related. There were two distinct benign liver tumor types: focal nodular hyperplasia and liver cell adenoma. Six benign liver tumors were examined for estrogen receptors. They did not contain significant quantities of estrogen receptor, supporting experimental studies of an epigenetic origin. Multiple tumors occurred in about 20% of cases but did not change the favorable prognosis associated with benign tumors. The most significant source of morbidity and mortality was spontaneous hemorrhage or rupture. Twenty-three women in this series had hepatocellular carcinoma and the majority of these were associated with prolonged steroid usage. These malignant liver tumors occurred in young females without cirrhosis or other factors known to be associated with hepatic malignancy. Unlike "hepatocellular carcinomas" reported in males taking anabolic androgenic steroids, the tumors in females had a high rate of metastasis to a variety of organs. The risk of liver tumors in oral contraceptive users remains unknown, but must be very small since an estimated 150 million women worldwide and 40 million in the U.S.A. have used oral contraceptives.

Toxicologic Pathology, Vol. 10, No. 2, 145-149 (1982)
DOI: 10.1177/019262338201000226


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?